Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The Zenith® Dissection Clinical Trial is a clinical trial approved by US FDA to study the safety and effectiveness of the Zenith® Dissection Endovascular System in the treatment of patients with aortic dissection.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Endovascular | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Zenith® Dissection Endovascular Graft | Device | Instead of making a large incision in the chest, the physician makes a small incision near each hip to insert, and guide the study device(s) into place in the aorta. |
| Measure | Description | Time Frame |
|---|---|---|
| Number of Patients With Major Complications | Major complication is defined as: Retrograde dissection, cardiac events requiring surgical management, prolonged ventilation requiring tracheotomy, renal failure requiring dialysis (where not previously needed), aortic fistula, mesenteric ischemia requiring surgical management, paralysis or paraparesis unresolved after 30 days of therapy, pulmonary embolism, stroke, and multi-system organ failure, unless related to presenting condition. | 30 days |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Joseph Lombardi, MD | The Cooper Health System | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Florida | Gainesville | Florida | 32610 | United States | ||
| Massachusetss General Hospital |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 31147139 | Derived | Lombardi JV, Cambria RP, Nienaber CA, Chiesa R, Mossop P, Haulon S, Zhou Q; STABLE I Investigators. Five-year results from the Study of Thoracic Aortic Type B Dissection Using Endoluminal Repair (STABLE I) study of endovascular treatment of complicated type B aortic dissection using a composite device design. J Vasc Surg. 2019 Oct;70(4):1072-1081.e2. doi: 10.1016/j.jvs.2019.01.089. Epub 2019 May 28. |
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Zenith® Dissection Endovascular Graft | The Zenith® Dissection Endovascular System is intended for the treatment of patients with aortic dissection of the descending thoracic aorta having anatomy amenable to endovascular repair. |
| Title | Milestones | Reasons Not Completed | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Zenith® Dissection Endovascular Graft | The Zenith® Dissection Endovascular System is intended for the treatment of patients with aortic dissection of the descending thoracic aorta having anatomy amenable to endovascular repair. |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Number of Patients With Major Complications | Major complication is defined as: Retrograde dissection, cardiac events requiring surgical management, prolonged ventilation requiring tracheotomy, renal failure requiring dialysis (where not previously needed), aortic fistula, mesenteric ischemia requiring surgical management, paralysis or paraparesis unresolved after 30 days of therapy, pulmonary embolism, stroke, and multi-system organ failure, unless related to presenting condition. | There were 8 patients experienced 30-day major complications. | Posted | Number | participants | 30 days |
|
30 days
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Zenith® Dissection Endovascular Graft | The Zenith® Dissection Endovascular System is intended for the treatment of patients with aortic dissection of the descending thoracic aorta having anatomy amenable to endovascular repair. |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Rupture of the aorta at the original entry tear | Vascular disorders | Systematic Assessment | Rupture was determined as the cause of death. Site reported that it was related to a pre-existing condition and not the device, clinical events committee (CEC) adjudicated that it was procedure and technique related. |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Arrhythmia requiring intervention or new treatment | Cardiac disorders | Systematic Assessment |
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Scott Snyder, PhD, Director of Clinical Science and Biostatistics | Cook Research Incorporated | 765-463-7537 | SSnyder@medinst.com |
Not provided
| ID | Term |
|---|---|
| D000784 | Aortic Dissection |
| D012421 | Rupture |
| ID | Term |
|---|---|
| D000094665 | Dissection, Blood Vessel |
| D000783 | Aneurysm |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Boston |
| Massachusetts |
| 02114 |
| United States |
| Cooper University Hospital | Camden | New Jersey | 08103 | United States |
| Cleveland Clinic | Cleveland | Ohio | 44195 | United States |
| Thomas Jefferson University Hospital | Philadephia | Pennsylvania | 19107 | United States |
| years |
|
| Gender | Count of Participants | Participants |
|
|
|
| 2 |
| 26 |
| 15 |
| 26 |
|
| Stroke, midbrain and cerebellar | Nervous system disorders | Systematic Assessment | Stroke was determined as the cause of death. clinical events committee (CEC) adjudicated that it was procedure related. |
|
| Refractory hypertension | Cardiac disorders | Systematic Assessment |
|
| Paralytic ileus > 4 days | Gastrointestinal disorders | Systematic Assessment |
|
| Stroke | Nervous system disorders | Systematic Assessment |
|
| Pleural effusion requiring treatment | Respiratory, thoracic and mediastinal disorders | Systematic Assessment |
|
| Pneumonia requiring antibiotics | Respiratory, thoracic and mediastinal disorders | Systematic Assessment |
|
| Pulmonary event requiring tracheostomy or chest tube | Respiratory, thoracic and mediastinal disorders | Systematic Assessment |
|
| Ventilation > 24 hours | Respiratory, thoracic and mediastinal disorders | Systematic Assessment |
|
| Renal failure requiring dialysis | Renal and urinary disorders | Systematic Assessment |
|
| Serum creatinine rise > 30% above baseline resulting in a persistent value > 2.0 mg/dl | Renal and urinary disorders | Systematic Assessment |
|
| Post-procedure transfusion | Vascular disorders | Systematic Assessment |
|
| Vascular injury | Vascular disorders | Systematic Assessment |
|
Not provided
| D000094683 |
| Acute Aortic Syndrome |
| D001018 | Aortic Diseases |
| D014947 | Wounds and Injuries |